摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl 4-(2-hydroxy-3-iodophenyl)butanoate | 136838-42-1

中文名称
——
中文别名
——
英文名称
Ethyl 4-(2-hydroxy-3-iodophenyl)butanoate
英文别名
——
Ethyl 4-(2-hydroxy-3-iodophenyl)butanoate化学式
CAS
136838-42-1
化学式
C12H15IO3
mdl
——
分子量
334.154
InChiKey
CMSFYZMPJYQZKK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    345.8±37.0 °C(Predicted)
  • 密度:
    1.574±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] METHODS FOR PRODUCING BERAPROST AND ITS DERIVATIVES<br/>[FR] PROCÉDÉS DE PRODUCTION DU BÉRAPROST ET SES DÉRIVÉS
    申请人:LUNG BIOTECHNOLOGY PBC
    公开号:WO2015179427A1
    公开(公告)日:2015-11-26
    The present invention is directed to methods for preparing Beraprost and novel synthetic intermediates for Beraprost. In one aspect, a process is provided to produce a pharmaceutical compound represented by the general Formula (I) via a radical cyclization route. The process is completed in fewer steps than the known synthetic methods and may be conducted to prepare commercially useful quantities. In another aspect, synthetic methods are provided for producing Beraprost and its derivatives,, which are stereoselective, efficient, scalable and economical. In another aspect, substantially isomerically pure compounds and intermediates are produced by the above processes.
    本发明涉及制备贝拉前列素(Beraprost)的方法以及贝拉前列素的新型合成中间体。在一个方面,提供了通过自由基环化路线生产一般式(I)代表的药物化合物的方法。该过程比已知的合成方法完成步骤更少,并可用于制备商业上有用的数量。在另一个方面,提供了用于生产贝拉前列素及其衍生物的合成方法,这些方法具有立体选择性,高效,可扩展和经济。在另一个方面,通过上述过程生产了基本异构纯化合物和中间体。
  • METHODS FOR PRODUCING BERAPROST AND ITS DERIVATIVES
    申请人:Lung Biotechnology PBC
    公开号:US20170166545A1
    公开(公告)日:2017-06-15
    The present invention is directed to methods for preparing Beraprost and novel synthetic intermediates for Beraprost. In one aspect, a process is provided to produce a pharmaceutical compound represented by the general Formula (I) via a radical cyclization route. The process is completed in fewer steps than the known synthetic methods and may be conducted to prepare commercially useful quantities. In another aspect, synthetic methods are provided for producing Beraprost and its derivatives, which are stereoselective, efficient, scalable and economical. In another aspect, substantially isomerically pure compounds and intermediates are produced by the above processes.
查看更多